Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Aemetis Inc. is positioned for substantial growth, with projected revenues increasing from $398 million in 2025 to $1.8 billion by 2036, reflecting an impressive eleven-year compound annual growth rate (CAGR) of approximately 14.4%. The company's ongoing operational execution and anticipated rebound of its India business, alongside cash flows from its renewable natural gas (RNG) operations and the potential IPO of its biodiesel segment in 2025, are anticipated to enhance its balance sheet significantly. Overall, the combination of these factors, coupled with a favorable revenue outlook, indicates a strong potential for Aemetis’s stock performance as it continues to capitalize on the transition to renewable fuels and chemicals.

Bears say

Aemetis Inc experienced a significant decline in revenue from its India operations, dropping to $3 million in Q4 2024 from $32 million in Q3 2024, indicating potential operational challenges in that segment. The company's net loss for Q4 2024 was reported at $16.2 million, which, while an improvement from the prior year's $25.4 million loss, still reflects ongoing financial difficulties. Additionally, the earnings per share of $(0.36) fell short of both the company's estimate and consensus expectations, highlighting concerns regarding profitability and revenue generation.

Aemetis (AMTX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Buy based on their latest research and market trends.

According to 8 analysts, Aemetis (AMTX) has a Buy consensus rating as of Aug 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.